Clinical trials demonstrate that discontinuation of semaglutide typically results in gradual weight regain, with patients recovering approximately two-thirds of lost weight within one year of stopping treatment, according to STEP trial extension data
We present the case of a 59-year-old woman with an extensive abdominal surgical history who developed small bowel obstruction (SBO) shortly after semaglutide administration
A registered dietitian can help you develop a practical, long-term eating plan that supports your Sembolic treatment
Semaglutide, originally developed as a medication for managing type 2 diabetes, has gained attention for its remarkable efficacy in promoting weight loss
Pirfenidone is a TGF- inhibitor, clinically used in the treatment of idiopathic pulmonary fibrosis and another study found that it markedly improved the pathological features of liver fibrosis in animals (273)
Throughout this article, therefore, any mention of semaglutide for weight loss refers to Wegovy, while references to semaglutide for blood sugar control refer to Ozempic